Study (year) | Technique | Sample size | True Positives | False Positives | False Negatives | True Negatives |
---|---|---|---|---|---|---|
Takashima et al. (1994) [9] | PGFNAB | 34 | 21 | 1 | 3 | 9 |
USGFNAB | 99 | 64 | 3 | 3 | 29 | |
Hatada et al. (1998) [11] | PGFNAB | 66 | 23 | 1 | 19 | 23 |
USGFNAB | 60 | 22 | 1 | 11 | 26 | |
Danese et al. (1998) [10] | PGFNAB | 522 | 79 | 136 | 7 | 300 |
USGFNAB | 535 | 99 | 126 | 3 | 307 | |
Carmeci et al. (1998) [12] | PGFNAB | 41 | 17 | 11 | 2 | 11 |
USGFNAB | 15 | 10 | 4 | 0 | 1 | |
Solymosi et al. (2001) [23] | PGFNAB | 317 | 19 | 101 | 6 | 191 |
USGFNAB | 380 | 35 | 102 | 3 | 240 | |
Goudy et al. (2005) [13] | PGFNAB | 18 | 5 | 1 | 0 | 12 |
USGFNAB | 11 | 2 | 5 | 0 | 4 | |
Cesur et al. (2006) [14] | PGFNAB | 18 | 4 | 3 | 2 | 9 |
USGFNAB | 22 | 6 | 2 | 1 | 13 | |
Izquierdo et al. (2006) [15] | PGFNAB | 23 | 7 | 5 | 4 | 7 |
USGFNAB | 5 | 3 | 1 | 0 | 1 | |
Can et al. (2008) [16] | PGFNAB | 15 | 2 | 1 | 0 | 12 |
USGFNAB | 22 | 8 | 3 | 0 | 11 | |
Krishnappa et al. (2013) [17] | PGFNAB | 25 | 6 | 1 | 5 | 13 |
USGFNAB | 25 | 9 | 1 | 2 | 13 | |
Sharma et al. (2017) [19] | PGFNAB | 49 | 5 | 6 | 1 | 37 |
USGFNAB | 80 | 3 | 3 | 1 | 73 |